Shape Therapeutics Funding: $147M Raised, Series B (2021)
Shape Therapeutics is based in Seattle. It has raised $147M in total funding. Latest round: Series B.
Shape Therapeutics funding overview
Shape Therapeutics is based in Seattle. Shape Therapeutics has raised $147M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in July 2021. The round record for Shape Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include New Enterprise Associates, CureDuchenne Ventures, Joe von Rickenbach, Min Cui, Highbury Group, Sofinnova Investments and 7 others. 13 distinct backers are named across the disclosed rounds.
Shape Therapeutics at a glance
Total raised
$147M
Latest round
Series B
Latest round date
July 2021
Headquarters
Seattle
Notable investors
New Enterprise Associates, CureDuchenne Ventures, Joe von Rickenbach, Min Cui, Highbury Group, Sofinnova Investments, VZVC, Mission BioCapital
Frequently asked about Shape Therapeutics funding
How much has Shape Therapeutics raised?
Shape Therapeutics has raised $147M in total disclosed funding across the rounds on record.
Who has invested in Shape Therapeutics?
New Enterprise Associates, CureDuchenne Ventures, Joe von Rickenbach, Min Cui, Highbury Group, Sofinnova Investments are named among the investors backing Shape Therapeutics.
What was the latest Shape Therapeutics funding round?
The most recent disclosed round is a Series B, announced in July 2021.
Where is Shape Therapeutics based?
Shape Therapeutics is based in Seattle.
When did Shape Therapeutics last raise?
The last disclosed Shape Therapeutics round closed in July 2021 at Series B.
Totals shown for Shape Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Seattle and the investors behind them below.
